Boditech Med Inc. (KOSDAQ:206640)

Market Cap	306.71B
Revenue (ttm)	149.40B
Net Income (ttm)	25.53B
Shares Out	21.78M
EPS (ttm)	1,168.13
PE Ratio	12.05
Forward PE	9.46
Dividend	150.00 (1.07%)
Ex-Dividend Date	Mar 31, 2025

Volume	91,062
Average Volume	55,136
Open	14,050
Previous Close	14,050
Day's Range	13,830 - 14,080
52-Week Range	13,350 - 18,670
Beta	0.13
RSI	44.07
Earnings Date	Nov 12, 2025

About Boditech Med

Boditech Med Inc. offers instruments and diagnostic reagents in South Korea and internationally. The company offers instruments, including ichroma II, diagnostic immuno-analyzer to measure the presence of various biomarkers for cardiac, cancer, hormones, infectious diseases, autoimmune diseases, and metabolic diseases; ichroma III, a high-throughput immuno-analyzer that enables simultaneous testing for various parameters; ExAmplar, a compact real time PCR that detects virus/bacteria quantitatively or qualitatively using ready-to-use cartridges;...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1998
• Employees: 541
• Stock Exchange: KOSDAQ
• Ticker Symbol: 206640

Financial Performance

In 2024, Boditech Med's revenue was 138.16 billion, an increase of 2.94% compared to the previous year's 134.22 billion. Earnings were 27.26 billion, an increase of 5.06%.